Anagrelide Capsules USP, 0.5 mg, 100-count bottles, Rx Only, Manufactured in India For: TEVA PHARMACEUTICALS USA, Inc., North Wales, PA 19454. NDC 0172-5241-60.
Published June 8, 2022 · Recall initiated: May 11, 2022
Summary
FDA records drug Class I recall D-0992-2022, published June 8, 2022 and initiated May 11, 2022. Recalling firm: Teva Pharmaceuticals USA Inc; Status: Terminated; Reported quantity: 4224 cartons; Lot: Lot # GD01090, Exp 05/2022. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications- Low Out-Of-Specification results obtained during stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Teva Pharmaceuticals USA Inc
- Distributor
- Distributed Nationwide in the USA
- Lot
- Lot # GD01090, Exp 05/2022
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA,July 19, 2023
- FDAFentanyl Buccal Tablets CII, 600mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only,May 31, 2023
- FDAFentanyl Buccal Tablets CII, 400mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only,May 31, 2023
- FDAFentanyl Buccal Tablets CII, 200mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only,May 31, 2023
- FDAAveeno Daily Moisturizing lotion Fragrance Free with Soothing Oat & Rich Emollients, Net Wt. 5 oz (141 g),June 8, 2022
- FDABBU Fine Whole Wheat Flour Bulk-AA-50251, Bulk Tanker; SG Whole Wheat Fine Flour 2,000 lb. Tote-AA StorageJune 8, 2022
Questions about this recall
Was Anagrelide Capsules USP, 0.5 mg, 100-count bottles, Rx Only, Manufactured in India For: TEVA PHARMACEUTICALS USA, Inc., North Wales, PA 19454. NDC 0172-5241-60. recalled?
Yes. FDA published recall D-0992-2022 on June 8, 2022. Reported hazard: Failed Dissolution Specifications- Low Out-Of-Specification results obtained during stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter